Sign in

CIK 0001601830

  • Large accelerated filer

RECURSION PHARMACEUTICALS, INC.

Sign in to watch
Ticker
RXRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464099738
Phone
+1 385-269-0203
Business address
41S RIO GRANDE STREET, SALT LAKE CITY, UT, 84101
Former names
Recursion Pharmaceuticals, LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$701,222
in 5 filings, $701K under 10b5-1 plans

Net −$701,222. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-11-20 Michor Franziska Director Grant or award · Stock Option (Right to Buy) +82,781 82,781
2024-11-15 Mauro David J Chief Medical Officer Shares withheld for taxes −4,187 $6.18 $26K 225,429
2024-11-15 Secora Michael Chief Financial Officer Shares withheld for taxes −11,937 $6.18 $74K 1,487,694
2024-11-15 Marriott Tina President and COO Shares withheld for taxes −14,286 $6.18 $88K 506,852
2024-11-15 Gibson Christopher Chief Executive Officer Shares withheld for taxes −26,023 $6.18 $161K 736,633
2024-11-14 Gibson Christopher Chief Executive Officer Conversion 10b5-1 +20,000 782,656
2024-11-14 Gibson Christopher Chief Executive Officer Sale 10b5-1 −20,000 $7.35 $147K 762,656
2024-11-14 Gibson Christopher Chief Executive Officer Conversion · Class B Common Stock 10b5-1 −20,000 6,056,700
2024-11-13 Gibson Christopher Chief Executive Officer Conversion 10b5-1 +20,000 782,656
2024-11-13 Gibson Christopher Chief Executive Officer Sale 10b5-1 −20,000 $7.74 $155K 762,656
2024-11-13 Gibson Christopher Chief Executive Officer Conversion · Class B Common Stock 10b5-1 −20,000 6,076,700
2024-11-13 Secora Michael Chief Financial Officer Exercise or conversion 10b5-1 +39,375 $2.22 $87K 1,514,631
2024-11-13 Secora Michael Chief Financial Officer Sale 10b5-1 −15,000 $7.66 $115K 1,499,631
2024-11-13 Secora Michael Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −39,375 337,635
2024-11-12 Borgeson Blake Director Sale 10b5-1 −11,447 $7.64 $87K 7,066,113
2024-11-12 Secora Michael Chief Financial Officer Exercise or conversion 10b5-1 +39,375 $2.22 $87K 1,490,256
2024-11-12 Secora Michael Chief Financial Officer Sale 10b5-1 −15,000 $7.64 $115K 1,475,256
2024-11-12 Secora Michael Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −39,375 377,010
2024-10-29 Borgeson Blake Director Sale 10b5-1 −11,447 $6.72 $77K 7,077,560
2024-10-24 Marriott Tina President and COO Exercise or conversion 10b5-1 +6,000 $1.06 $6K 527,138

Page 13 of 41 · 805 trades